Antitumour imidazotetrazines—XVI
- 1 October 1987
- journal article
- research article
- Published by Elsevier in Biochemical Pharmacology
- Vol. 36 (19) , 3215-3220
- https://doi.org/10.1016/0006-2952(87)90636-8
Abstract
No abstract availableThis publication has 15 references indexed in Scilit:
- Antitumour imidazotetrazines—XVBiochemical Pharmacology, 1987
- In vivo studies with the novel anticancer agent mitozolomide (NSC 353451) on Lewis lung carcinomaCancer Chemotherapy and Pharmacology, 1986
- Antitumour imidazotetrazines—XBiochemical Pharmacology, 1986
- Differential cytotoxicity and DNA-damaging effects produced in human cells of the Mer+ and Mer− phenotypes by a series of alkyltriazenylimidazolesCarcinogenesis: Integrative Cancer Research, 1985
- Antitumour imidazotetrazines—IVBiochemical Pharmacology, 1984
- Antitumour imidazotetrazines. 1. Synthesis and chemistry of 8-carbamoyl-3-(2-chloroethyl)imidazo[5,1-d]-1,2,3,5-tetrazin-4(3H)-one, a novel broad-spectrum antitumor agentJournal of Medicinal Chemistry, 1984
- Alkylation of isolated chromatin with N-methyl-N-nitrosourea and N-ethyl-N-nitrosoureaChemico-Biological Interactions, 1983
- Studies on the mechanism of action of the tumour inhibitory triazenesBiochemical Pharmacology, 1973
- A new fluorometric method for RNA and DNA determinationAnalytical Biochemistry, 1966
- The Determination of Nucleic AcidsPublished by Wiley ,1966